Position in IQV
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$949,737
+$327,831 QoQ
Shares Held
5,569
+101.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Brooklyn Investment Group holds $19,927,193 across 17 Diagnostics & Research names. IQV ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,289 | $5,548,882 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
4,901 | $2,753,822 | |
| 3 | DHR |
Danaher Corp /De/
|
12,121 | $2,298,141 | |
| 4 | A |
Agilent Technologies, Inc.
|
11,896 | $1,355,906 | |
| 5 | ILMN |
Illumina, Inc.
|
10,736 | $1,323,319 | |
| 6 | LH |
Labcorp Holdings Inc.
|
3,774 | $1,006,940 | |
| 7 | IQV |
Iqvia Holdings Inc.
This page
|
5,569 | $949,737 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
587 | $740,324 |
All Filings in IQV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $949,737 | 5,569 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $621,906 | 2,759 | Shares | Defined | 2026-02-12 | |
| 2025-03-31 | $151,265 | 858 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $164,085 | 835 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $198,106 | 836 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $183,952 | 870 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $220,014 | 870 | Shares | Defined | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||